KEI Briefing Note 2020:1 Role of the Federal Government in the Development of GS-5734/Remdesivir

KEI Briefing Note 2020:1: Role of the U.S. Federal Government in the Development of GS-5734/Remdesivir
Kathryn Ardizzone. March 20, 2020. (Updated May 28, 2020)

KEI-Briefing-Note-2020_1GS-5734-Remdesivir